Evidence map›Paper›PMID 36674566›Full record

ArticleInternational journal of molecular sciences2023

Amphiphilic Polypeptides Obtained by the Post-Polymerization Modification of Poly(Glutamic Acid) and Their Evaluation as Delivery Systems for Hydrophobic Drugs.

Apollinariia Yu Dzhuzha, Irina I Tarasenko, Leonard Ionut Atanase, Antonina Lavrentieva, Evgenia G Korzhikova-Vlakh

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Biopolymers for Enhanced Health Benefits.International journal of molecular sciences · 2023
    Article
  4. Article
  5. Article
  6. Nanogels as novel drug nanocarriers for CNS drug delivery.Frontiers in molecular biosciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Apollinariia Yu DzhuzhaInstitute of Chemistry, Saint-Petersburg State University, 198504 St. Petersburg, Russia.
Irina I TarasenkoInstitute of Macromolecular Compounds, Russian Academy of Sciences, 199004 St. Petersburg, Russia.
Leonard Ionut AtanaseFaculty of Dental Medicine, "Apollonia" University, 700399 Iasi, Romania.ORCID 0000-0002-3657-1492
Antonina LavrentievaInstitute of Technical Chemistry, Gottfried-Wilhelm-Leibniz University, 30167 Hannover, Germany.ORCID 0000-0003-0003-5572
Evgenia G Korzhikova-VlakhInstitute of Macromolecular Compounds, Russian Academy of Sciences, 199004 St. Petersburg, Russia.ORCID 0000-0002-2530-7709

Funding

Russian Science Foundation 21-73-20104
6 · The paper itself

Abstract

Synthetic poly(amino acids) are a unique class of macromolecules imitating natural polypeptides and are widely considered as carriers for drug and gene delivery. In this work, we synthesized, characterized and studied the properties of amphiphilic copolymers obtained by the post-polymerization modification of poly(α,L-glutamic acid) with various hydrophobic and basic L-amino acids and D-glucosamine. The resulting glycopolypeptides were capable of forming nanoparticles that exhibited reduced macrophage uptake and were non-toxic to human lung epithelial cells (BEAS-2B). Moreover, the developed nanoparticles were suitable for loading hydrophobic cargo. In particular, paclitaxel nanoformulations had a size of 170-330 nm and demonstrated a high cytostatic efficacy against human lung adenocarcinoma (A549). In general, the obtained nanoparticles were comparable in terms of their characteristics and properties to those based on amphiphilic (glyco)polypeptides obtained by copolymerization methods.

Indexed as

Glutamic AcidNanoparticlesAmino AcidsDrug CarriersDrug Delivery SystemsHumansPeptidesPolymerizationAmino AcidsDrug CarriersGlutamic AcidPeptidesamphiphilic poly(amino acids)drug deliveryhydrophobic drugsnanoparticlespaclitaxelpolypeptidespost-polymerization modification

Identifiers

PMID36674566
PMCPMC9864831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.